Background Mammary analog secretory carcinoma of the salivary glands (MASCSG) is a
newly introduced malignant tumor of the salivary glands. For decades, it has been confused …

Objective The aim of this systematic review was to describe the epidemiology, diagnostic
criteria, differential diagnosis, treatment, prognostic factors, and treatment outcomes of …

Objectives Secretory Carcinoma is a malignant salivary gland tumor, initially described in
2010. This rare tumor is associated with the translocation t (12; 15)(p13; q25), resulting in …

Secretory carcinoma (SC) of the salivary gland was recently added to the fourth edition of
the World Health Organization classification of head and neck tumors. Some salivary tumors …

Context.—The head and neck regions have complex anatomic structures. They are not
exempted from the rare occurrences of highly unusual, diagnostically challenging malignant …

Secretory carcinoma (SC) is an uncommon salivary gland neoplasm of the oral cavity that
microscopically may mimic acinic cell carcinoma (ACC) and mucoepidermoid carcinoma …

Mammary analogue secretory carcinoma (MASC) is a rare and recently described tumour of
the salivary glands. MASC has similar histomorphological and immunohistochemical …

Context.—Neurotrophic receptor tyrosine kinase (NTRK) fusion testing has both diagnostic
and therapeutic implications for patient care. With 2 tumor-agnostic US Food and Drug …

Conclusion: It is highly likely for many cases of SC to be initially diagnosed as acinic cell
carcinoma (AciCC) owing to their similar histological findings. The treatment strategy for …

Secretory carcinoma (SC), previously described as mammary analogue secretory carcinoma
(MASC), is a recently described salivary gland tumor which morphologically resembles …